- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
Study: ER visits climb for misuse of Rxs, OTCs
Emergency room visits related to the nonmedical use of pharmaceuticals, including Rx and OTC drugs, increased 21% from 2004 to 2005.
Emergency room visits related to the nonmedical use of pharmaceuticals, including Rx and OTC drugs, increased 21% from 2004 to 2005, according to the latest estimates from the Drug Abuse Warning Network (DAWN), 2005: National Estimates of Drug-Related Emergency Department Visits. The number of visits related to illicit drug use or alcohol was unchanged for the same time period. The DAWN report, published by the Substance Abuse and Mental Health Services Administration, shows that the total number of drug-related ER visits remained stable from 2004 to 2005. However, visits involving the nonmedical use of Rxs and OTCs increased from 495,732 to 598,542. The majority of these visits involved multiple drugs. Antianxiety drugs (benzodiazepines, up 19%), prescription pain relievers (up 24%), and methadone (up 29%) were among those most frequently implicated in nonmedical use.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Examining Barriers to Care in Diabetic Retinopathy Screening
November 30th 2023Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.
